SCHEMBL28502500

SCHEMBL28502500

Cc1c(C(N)=O)ccc(-c2c[nH]c3ncc(-c4ccc(CN5CCN(C)CC5)cc4)cc23)c1C

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K11 Q16584 9/20 0.73
TNIK Q9UKE5 12/20 0.64
MAP4K1 Q92918 1/20 0.62
IKBKB O14920 2/20 0.60
CHUK O15111 2/20 0.60
ABL1 P00519 2/20 0.60
INSR P06213 2/20 0.60
CDK2 P24941 2/20 0.60
FLT3 P36888 2/20 0.60
SGK1 O00141 1/20 0.59
AURKA O14965 1/20 0.59
PRKAB2 O43741 1/20 0.59
ROCK2 O75116 1/20 0.59
NTRK1 P04629 1/20 0.59
LCK P06239 1/20 0.59
CDK1 P06493 1/20 0.59
IGF1R P08069 1/20 0.59
MET P08581 1/20 0.59
CYP3A4 P08684 1/20 0.59
SRC P12931 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28513743 0.87 MAP4K1 (0.60) MAP3K11TNIKMAP4K1
SCHEMBL28503233 0.85 MAP3K11 (0.54) MAP3K11TNIKMAP4K1IKBKBCHUK
SCHEMBL722116 0.85 MAP3K11 (1.00) MAP3K11TNIKMAP4K1IKBKBCHUK
SCHEMBL723895 0.85 MAP3K11 (1.00) MAP3K11TNIKMAP4K1IKBKBCHUK
SCHEMBL28511325 0.84 MAP4K1 (0.57) MAP3K11TNIKMAP4K1
SCHEMBL28499626 0.84 MAP4K1 (0.61) MAP3K11TNIKMAP4K1
SCHEMBL28514908 0.84 MAP4K1 (0.58) MAP3K11TNIKMAP4K1ABL1INSR
SCHEMBL28510070 0.84 MAP3K11 (0.53) MAP3K11TNIKMAP4K1IKBKBCHUK
SCHEMBL28506325 0.83 MAP4K1 (0.57) MAP3K11TNIKMAP4K1ABL1INSR
SCHEMBL15154839 0.82 MAP3K11 (0.85) MAP3K11TNIKMAP4K1IKBKBCHUK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112243439-A Pyrrolo [2,3-B ] pyridines or pyrrolo [2,3-B ] pyrazines as HPK1 inhibitors and uses thereof 百济神州有限公司 2021-01-19 CN disclosed